Fate Therapeutics, Inc.
NASDAQ:FATE · NASDAQ Global Market
-$0.00 today
Vol 4.12M · Avg 2.92M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+83.33%
Period High
$2.84
Period Low
$0.92
Latest
$2.09
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Prelude Therapeutics Incorporated
NASDAQ:PRLD
$329.69M
Nkarta, Inc.
NASDAQ:NKTX
$196.46M
Alector, Inc.
NASDAQ:ALEC
$181.53M
Molecular Partners AG
NASDAQ:MOLN
$146.29M
Acumen Pharmaceuticals, Inc.
NASDAQ:ABOS
$137.80M
PepGen Inc.
NASDAQ:PEPG
$124.16M
Corbus Pharmaceuticals Holdings, Inc.
NASDAQ:CRBP
$101.98M
Vor Biopharma Inc.
NASDAQ:VOR
$98.90M
Cassava Sciences, Inc.
SAVA
$63.77M
Inovio Pharmaceuticals, Inc.
NASDAQ:INO
$58.68M
What is the latest FATE filing?
The latest filing shown is 4 dated Jun 15, 2026.
How many recent filings does FATE have?
Intrinsic Alpha currently shows 20 recent filings for FATE.
Explore More
Continue the stock analysis
Jump to another research area for this company.